CHRISTUS MF - SULPHUR SPRINGS — History
CCN 450236 | 3-year financial timeline | COVID resilience: 16/100
🛡️ Public data only — no PHI permitted on this instance.
$121M
Latest Revenue (FY2022)
-17.1%
Revenue CAGR (3yr)
9.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $177M | $112M | $121M | +8.3% | -17.1% |
| Operating Expenses | $92M | $101M | $109M | +8.2% | +8.9% |
| Operating Margin | 47.7% | 9.8% | 9.8% | +0.2% | -54.6% |
| Net Income | $84M | $11M | $12M | +8.5% | -62.4% |
| Licensed Beds | 56 | 56 | 56 | +0.0% | +0.0% |
| Total Patient Days | 13,447 | 14,448 | 12,195 | -15.6% | -4.8% |
| Medicare Day % | 37% | 32% | 31% | -1.7% | -7.9% |
| Medicaid Day % | 2% | 3% | 2% | -27.8% | +3.4% |
COVID Impact & Recovery
Resilience Score: 16/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -31.3% ($177M → $121M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-17.1%
This Hospital
+7.6%
State Avg
Latest Margin
9.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $94M | -9.1% |
| FY2024 (proj) | $66M | -28.1% |
| FY2025 (proj) | $39M | -47.0% |